The deal will help boost Sun Pharma’s presence in the high-value specialty drug area in the neurological and critical ...

The new entity is proposed to be named Paras Heven Advanced Drones and will be registered in India with an authorised capital ...

The company's net profit jumped 73.2% YoY to ₹432.2 crore in Q4FY25 against ₹249.6 crore in the year-ago quarter.

This will be achieved by building the 2000 MWac (2600 MW DC) across the Anantapuramu and Sri Sathya Sai districts.

The company's revenue from operations increased 15.8% yoy to ₹1,212.59 crore in Q4 FY25 compared to ₹1,047.08 crore in Q4 ...

Pharmazz has two late-stage pipeline drug candidates Sovateltide (for treatment of acute cerebral ischemic stroke) and ...

Zydus Lifesciences has received final approval from the USFDA to launch its isotretinoin capsules USP in six different ...

The company posted a net profit of ₹1,501 crore, around 14% more than the ₹1,322 crore it earned in the corresponding quarter ...

In the financial year ended 2025, the business added 257 new stores. In the previous comparable period, the business opened ...

The business reported that the robust bottomline growth was backed by a sharp increase in topline as well as stable operating ...

Fin stabilizers are used to reduce ship roll and improve stability during navigation of warships and helicopters in rough ...

As per the company, with this investment, Odisha has become the largest investment destination for the company.